Jump to Content Jump to Main Navigation
User Account
  • Sign In to save searches and organize your favorite content.
  • Not registered? Sign up
  • My Content (0)
  • Searches (0)
More
  • Subscriptions
  • Join E-mail List
  • Help
JNCCN
Menu
  • Home
  • Content
    • Current Issue
    • Past Issues
    • Online First
    • Supplements
    • NCCN Meeting Highlights
    • JNCCN In the News
  • COVID-19
  • CE
  • JNCCN 360
  • Author Center
    • Call for Papers
    • Submit a Manuscript
    • Information for Authors
    • Reprints/Permissions
  • About
    • JNCCN
    • Editorial Board
    • Editorial Calendar
    • NCCN
    • Harborside
Search
Close
Advanced Search Help

Volume 18 (2020): Issue 12.5 (Dec 2020): Highlights of the NCCN 2020 Virtual Congress: Hematologic Malignancies

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
  • Get eTOC Alerts
  • Get Ahead of Print Alerts
  • Citation Alert
  • Highlights of the NCCN 2020 Virtual Congress: Hematologic Malignancies
    • The NCCN 2020 Virtual Congress: Hematologic Malignancies
    • Lymphoma 101: The Plot Thickens
    • Navigating the Jargon of Molecular Testing in Non-Hodgkin Lymphoma
    • Controversies in the Management of Early-Stage Hodgkin Lymphoma
    • Updates in the Management of CLL/SLL: Sequencing Therapy and the Role of Minimal Residual Disease Testing
    • Challenges and Opportunities in Marginal Zone Lymphoma: Implications of Biology on Treatment
    • Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma: Is It Time to Consider CAR-T for All?
    • Peripheral T-Cell Lymphomas–Not Otherwise Specified: A Shrinking Entity?
    • Evolving Concepts in the Diagnosis and Staging of Multiple Myeloma
    • Bonanza of New Treatment Regimens for Multiple Myeloma: What Is Right for My Patient?
    • Smoldering Multiple Myeloma: What Is the Threshold to Start Treatment?
    • Emerging Therapeutic Options in Acute Lymphoblastic Leukemia
    • Advances in Acute Myeloid Leukemia Management: Focus on Secondary Disease and Older Patients
    • Myeloproliferative Neoplasms: Emerging Treatment Options for Myelofibrosis
  • Collapse
  • Expand
  • Advertising
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Permissions
  • Disclaimer

© 2019-2020 National Comprehensive Cancer Network

Follow us on: Share Share Share

Powered by:

PubFactory
  • [3.239.233.139]
  • 3.239.233.139
Close
Edit

Character limit 500/500

@!

Character limit500/500